Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63

Characteristics of selected major statin trials

Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63

Updated meta-analysis of major statin trials that assessed the effect of statins on fatal and non-fatal stroke

Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63

Updated meta-analysis of major statin trials that assessed the effect of statins on fatal stroke

Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63

Updated meta-analysis of major statin trials that assessed the effect of statins on haemorrhagic stroke

Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63

Association between reduction in LDL cholesterol concentration with stroke incidence among the major statins trials

Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63

Meta-analysis of statin trials that assessed the effect of intensive lipid-lowering therapy versus standard statin therapy on incidence

of fatal and non-fatal stroke and on major cardiovascular events

Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63